Results 201 to 210 of about 492,575 (295)
The plasmid-host fitness landscape: a new paradigm for predicting the fate of mobile resistance. [PDF]
Abdulqadir HN.
europepmc +1 more source
Objective There is growing interest in evaluating new strategies to delay or prevent posttraumatic osteoarthritis (PTOA) in individuals who have sustained anterior cruciate ligament (ACL) injury. This study sought to determine characteristics of potential treatments that are acceptable to patients with ACL injury. Methods Participants with a history of
Kevin Kennedy +9 more
wiley +1 more source
Heuristically Adaptive Diffusion-Model Evolutionary Strategy. [PDF]
Hartl B, Zhang Y, Hazan H, Levin M.
europepmc +1 more source
Objective We evaluated the ability of the Renal Activity Index for Lupus (RAIL) to discriminate active lupus nephritis (LN) in adult patients with active systemic lupus erythematosus (SLE) and differentiate LN treatment response. Methods Urine samples from adults with biopsy‐proven active class III and IV LN from TULIP‐LN (active LN group ...
Hermine I. Brunner +12 more
wiley +1 more source
A Concept Using α-Niche Evolution Within Bacterial Communities to Direct β-Niche Evolution of Focal Species. [PDF]
Scheuerl T, Rivett DW.
europepmc +1 more source
Objective Relapsing polychondritis (RP) is a rare disease defined by recurrent cartilaginous inflammation. Anti–collagen II (Col2) antibodies have been proposed as a diagnostic biomarker for RP, but their performance characteristics are not well defined.
Karyssa Stonick +6 more
wiley +1 more source
Greater climate change adaptation potential in populations of Quercus macrocarpa at edges of latitudinal gradient. [PDF]
Rea LMS +8 more
europepmc +1 more source
Fitness ameliorates genetic risk of heart disease [PDF]
openaire +2 more sources
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; ClinicalTrials.gov identifier ...
Hermine I. Brunner +14 more
wiley +1 more source

